How Much Does Leqembi (Lecanemab) Cost?
How much infusions of this new Alzheimer’s drug cost (with and without insurance) and how patients can lower the cost.
How Remicade works, how long it takes to work, cost, side effects, and more.
Remicade is the brand name for a monoclonal antibody (infliximab) used to treat several autoimmune diseases including Crohn’s disease, ulcerative colitis, rheumatoid arthritis (in combination with methotrexate), Ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.
Below, find information on:
How Remicade works
Remicade inhibits the action of a protein produced by the immune system known as tumor necrosis factor-alpha (TNF-alpha), which causes the immune system to attack healthy parts of the body. Those suffering from certain diseases may have too much TNF-alpha.
Full prescribing information from Janssen can be found here.
READ MORE: Remicade Infusion: What To Expect & How To Prepare
Conditions Remicade is prescribed for
How to get a physician referral for Remicade
First, take a trip to your doctor’s office to discuss potential risk factors. Tell your doctor if:
Once your doctor has cleared you to use Remicade and provided a referral, you can proceed to book an infusion appointment.
How long Remicade takes to work
Depending on what you're treating, you may be on Remicade for several weeks to several months. For some conditions like IBD, you may need to be on Remicade for the long term, in which case you’ll need constant reassessment from a healthcare professional to confirm its continued efficacy.
READ MORE: How Long Does It Take For Remicade Infusions To Work?
How much Remicade infusion costs
The cost of Remicade can range between $3k-$12k per treatment, totaling upwards of $50k-150k per year — although keep in mind that the amount you’ll pay out-of-pocket depends on a variety of factors, including your site of treatment (hospital, infusion center, home infusion) and insurance coverage.
READ MORE: How Much Does Remicade Infusion Cost?
Potential side effects of Remicade
Acute (i.e. immediate) infusion-related reactions that may develop during treatment in adult patients (and typically subside over time) include flu-like symptoms (e.g., fever/sweating and sinus infections/sore throat), blood pressure variations, nausea, and itching. IBD patients who develop antibodies to infliximab have a higher risk of developing acute allergic reactions.
Delayed reactions that develop within 3-12 days after infusion may include muscle/joint pain, tiredness, stomach pain, and rashes.
If you're worried about rare but more serious infections, side effects, or medical conditions such as weight gain, nervous system disorders, liver injury/liver failure, hepatosplenic t-cell lymphoma or skin cancer, please let your dedicated Infusion Guide know. We'd be happy to discuss further with you and provide medical advice.
Also, keep in mind that select reactions to Remicade can be managed using meds (epinephrine, diphenhydramine, acetaminophen, etc).
If you are taking Remicade, you cannot receive live vaccines (flu, Covid, etc) or receive treatment with weakened bacteria (e.g., BCG for bladder cancer).
How Remicade compares to other medications
Inflectra vs Remicade
Inflectra and Remicade are two biological medications used to fight chronic inflammatory autoimmune disorders, including Inflammatory Bowel Disease (IBD). The FDA approved Inflectra as a biosimilar to Remicade based on the review of clinical safety and effectiveness data.
Both these biologic drugs treat the same autoimmune disorders. They’re infused into your vein and are often given once every six to eight weeks. They’re both TNF blockers, meaning they work the same way by blocking a protein called tumor necrosis factor (TNF)-alpha. There aren’t any clinically meaningful safety or effectiveness differences between them.
READ MORE: Inflectra vs Remicade: What’s The Difference?
Entyvio vs Remicade
Entyvio and Remicade are biosimilars, meaning they are highly similar biological medications (although they belong to different drug classes). Entyvio is a brand name prescription medication that belongs to a drug class called integrin receptor antagonists, while Remicade belongs to a drug class called tumor necrosis factor (TNF)-alpha inhibitors.
READ MORE: Entyvio vs Remicade: What’s The Difference?
Stelara vs Remicade
The main difference between these medications is that Stelara requires one initial intravenous infusion dose, followed by maintenance subcutaneous injections every 8 weeks. Remicade, on the other hand, requires intravenous doses at weeks 0, 2, and 6, followed by maintenance doses every 8 weeks.
READ MORE: Stelara vs Remicade: What's The Difference?
Interested in Remicade treatment at Local Infusion?
Local Infusion offers modern, state-of-the-art centers with private suites, designed with your comfort in mind.
From questions on what to expect in your first treatment, to providing financial guidance and support, a dedicated Infusion Guide works with you and your physician to provide clear answers and assistance every step of the way. Plus, we take care of everything having to do with prior authorization.
We’ll reach out within hours of a physician referral and get you digitally on board in less than two minutes, allowing our staff more time to focus on you.
Should you have questions regarding pricing and insurance, our team will work with you to provide financial assistance support and minimize costs, providing a simple and stress-free experience.
How much infusions of this new Alzheimer’s drug cost (with and without insurance) and how patients can lower the cost.
How Remicade works, how long it takes to work, cost, side effects, and more.
Living with rheumatoid arthritis (RA) can present unique challenges, but making informed choices about what you eat can have a significant impact on...